<SEC-DOCUMENT>0001213900-25-110087-index.html : 20251113 <SEC-HEADER>0001213900-25-110087.hdr.sgml : 20251113 <ACCEPTANCE-DATETIME>20251113165716 ACCESSION NUMBER: 0001213900-25-110087 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20251113 FILED AS OF DATE: 20251113 DATE AS OF CHANGE: 20251113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Scinai Immunotherapeutics Ltd. CENTRAL INDEX KEY: 0001611747 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37353 FILM NUMBER: 251479480 BUSINESS ADDRESS: STREET 1: JERUSALEM BIOPARK, 2ND FLOOR STREET 2: HADASSAH EIN KEREM CAMPUS CITY: JERUSALEM STATE: L3 ZIP: 00000 BUSINESS PHONE: 972-8-9302529 MAIL ADDRESS: STREET 1: JERUSALEM BIOPARK, 2ND FLOOR STREET 2: HADASSAH EIN KEREM CAMPUS CITY: JERUSALEM STATE: L3 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: BiondVax Pharmaceuticals Ltd. DATE OF NAME CHANGE: 20140624 </SEC-HEADER> <DOCUMENT> <TYPE>6-K <SEQUENCE>1 <FILENAME>ea0265587-6k_scinai.htm <DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER <TEXT> Document 1 - file: ea0265587-6k_scinai.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>ea026558701ex99-1_scinai.htm <DESCRIPTION>NOTICE AND PROXY STATEMENT OF ANNUAL GENERAL MEETING OF SHAREHOLDERS <TEXT> Document 2 - file: ea026558701ex99-1_scinai.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>3 <FILENAME>ea026558701ex99-2_scinai.htm <DESCRIPTION>PROXY CARD <TEXT> Document 3 - file: ea026558701ex99-2_scinai.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>ex99-2_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: ex99-2_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>ex99-2_002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: ex99-2_002.jpg
</DOCUMENT> </SEC-DOCUMENT>